Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia

The safety profile of deferasirox

Ali T. Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Raffaella Origa, Zeynep Karakas, Dany Habr, Zewen Zhu, M. Domenica Cappellini

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: Patients with non-transfusion-dependent thalassemia (NTDT) often develop iron overload and related complications, and may require iron chelation. However, the risk of over-chelation emerges as patients reach low, near-normal body iron levels and dose adjustments may be needed. In the THALASSA study, the threshold for chelation interruption was LIC

Original languageEnglish
Pages (from-to)521-526
Number of pages6
JournalEuropean Journal of Haematology
Volume92
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Thalassemia
Iron
Safety
Iron Overload
Liver
deferasirox

Keywords

  • Iron chelation
  • Iron overload
  • Thalassemia

ASJC Scopus subject areas

  • Hematology

Cite this

Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia : The safety profile of deferasirox. / Taher, Ali T.; Porter, John B.; Viprakasit, Vip; Kattamis, Antonis; Chuncharunee, Suporn; Sutcharitchan, Pranee; Siritanaratkul, Noppadol; Origa, Raffaella; Karakas, Zeynep; Habr, Dany; Zhu, Zewen; Cappellini, M. Domenica.

In: European Journal of Haematology, Vol. 92, No. 6, 2014, p. 521-526.

Research output: Contribution to journalArticle

Taher, AT, Porter, JB, Viprakasit, V, Kattamis, A, Chuncharunee, S, Sutcharitchan, P, Siritanaratkul, N, Origa, R, Karakas, Z, Habr, D, Zhu, Z & Cappellini, MD 2014, 'Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: The safety profile of deferasirox', European Journal of Haematology, vol. 92, no. 6, pp. 521-526. https://doi.org/10.1111/ejh.12270
Taher, Ali T. ; Porter, John B. ; Viprakasit, Vip ; Kattamis, Antonis ; Chuncharunee, Suporn ; Sutcharitchan, Pranee ; Siritanaratkul, Noppadol ; Origa, Raffaella ; Karakas, Zeynep ; Habr, Dany ; Zhu, Zewen ; Cappellini, M. Domenica. / Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia : The safety profile of deferasirox. In: European Journal of Haematology. 2014 ; Vol. 92, No. 6. pp. 521-526.
@article{5eae276709914b7b9ac5cbadce807d0d,
title = "Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: The safety profile of deferasirox",
abstract = "Objective: Patients with non-transfusion-dependent thalassemia (NTDT) often develop iron overload and related complications, and may require iron chelation. However, the risk of over-chelation emerges as patients reach low, near-normal body iron levels and dose adjustments may be needed. In the THALASSA study, the threshold for chelation interruption was LIC",
keywords = "Iron chelation, Iron overload, Thalassemia",
author = "Taher, {Ali T.} and Porter, {John B.} and Vip Viprakasit and Antonis Kattamis and Suporn Chuncharunee and Pranee Sutcharitchan and Noppadol Siritanaratkul and Raffaella Origa and Zeynep Karakas and Dany Habr and Zewen Zhu and Cappellini, {M. Domenica}",
year = "2014",
doi = "10.1111/ejh.12270",
language = "English",
volume = "92",
pages = "521--526",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia

T2 - The safety profile of deferasirox

AU - Taher, Ali T.

AU - Porter, John B.

AU - Viprakasit, Vip

AU - Kattamis, Antonis

AU - Chuncharunee, Suporn

AU - Sutcharitchan, Pranee

AU - Siritanaratkul, Noppadol

AU - Origa, Raffaella

AU - Karakas, Zeynep

AU - Habr, Dany

AU - Zhu, Zewen

AU - Cappellini, M. Domenica

PY - 2014

Y1 - 2014

N2 - Objective: Patients with non-transfusion-dependent thalassemia (NTDT) often develop iron overload and related complications, and may require iron chelation. However, the risk of over-chelation emerges as patients reach low, near-normal body iron levels and dose adjustments may be needed. In the THALASSA study, the threshold for chelation interruption was LIC

AB - Objective: Patients with non-transfusion-dependent thalassemia (NTDT) often develop iron overload and related complications, and may require iron chelation. However, the risk of over-chelation emerges as patients reach low, near-normal body iron levels and dose adjustments may be needed. In the THALASSA study, the threshold for chelation interruption was LIC

KW - Iron chelation

KW - Iron overload

KW - Thalassemia

UR - http://www.scopus.com/inward/record.url?scp=84900489981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900489981&partnerID=8YFLogxK

U2 - 10.1111/ejh.12270

DO - 10.1111/ejh.12270

M3 - Article

VL - 92

SP - 521

EP - 526

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 6

ER -